Literature DB >> 12584684

Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs.

Julie R Fischer1, Kenneth R Harkin, Lisa C Freeman.   

Abstract

Randomized crossover studies were performed to determine the effect of coadministration of d-alpha-tocopheryl polyethylene glycol 1,000 succinate (vitamin E TPGS) on the oral bioavailability of cyclosporine A (CsA) formulated as either Sandimmune (Novartis Pharmaceuticals) or Neoral (Novartis Pharmaceuticals). Healthy dogs were given a single oral dose of each cyclosporine formulation with and without vitamin E TPGS. Blood samples were collected from each dog before and at various intervals for 24 hours after drug administration. Whole-blood CsA concentrations were determined by high-pressure liquid chromatography. Noncompartmental pharmacokinetic analysis showed that coadministration of vitamin E TPGS increased the oral bioavailability of Sandimmune. The bioavailability of Neoral was greater than that of cyclosporine. Concurrent administration of vitamin E TPGS had no consistent effect on the bioavailability of Neoral.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12584684

Source DB:  PubMed          Journal:  Vet Ther        ISSN: 1528-3593


  8 in total

1.  A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide delivery.

Authors:  Xiaojuan Yang; Yong Peng; Bo Yu; Jianhua Yu; Chenguang Zhou; Yicheng Mao; L James Lee; Robert J Lee
Journal:  Mol Pharm       Date:  2011-03-23       Impact factor: 4.939

2.  Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment.

Authors:  Yuandong Ma; Yi Zheng; Kexin Liu; Ge Tian; Yan Tian; Lei Xu; Fei Yan; Laiqiang Huang; Lin Mei
Journal:  Nanoscale Res Lett       Date:  2010-05-06       Impact factor: 4.703

3.  In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy.

Authors:  Zhiping Zhang; Sie Huey Lee; Chee Wee Gan; Si-Shen Feng
Journal:  Pharm Res       Date:  2008-05-29       Impact factor: 4.200

4.  Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.

Authors:  Qiuchen Chu; Hong Xu; Meng Gao; Xin Guan; Hongyan Liu; Sa Deng; Xiaokui Huo; Kexin Liu; Yan Tian; Xiaochi Ma
Journal:  Int J Nanomedicine       Date:  2016-01-27

5.  Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs.

Authors:  Tarini Ullal; Yoko Ambrosini; Sangeeta Rao; Cynthia R L Webster; David Twedt
Journal:  J Vet Intern Med       Date:  2019-08-08       Impact factor: 3.333

Review 6.  Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases.

Authors:  Ajay Srivastava; Rajiv Lall; Jamil Talukder; Dan DuBourdieu; Ramesh C Gupta
Journal:  Molecules       Date:  2019-11-25       Impact factor: 4.411

Review 7.  Thiolated-Polymer-Based Nanoparticles as an Avant-Garde Approach for Anticancer Therapies-Reviewing Thiomers from Chitosan and Hyaluronic Acid.

Authors:  Roberto Grosso; M-Violante de-Paz
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

Review 8.  Oral cyclosporine treatment in dogs: a review of the literature.

Authors:  T M Archer; D M Boothe; V C Langston; C L Fellman; K V Lunsford; A J Mackin
Journal:  J Vet Intern Med       Date:  2013-12-16       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.